Wednesday - October 21, 2026
Dana-Farber presents phase 3 lung cancer data in ESMO presidential symposium
October 20, 2026
BOSTON, Massachusetts, Oct. 20 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:

* * *

Dana-Farber presents phase 3 lung cancer data in ESMO presidential symposium

*

Additional key study updates in prostate, breast and kidney cancer, and a special symposium focused on personalized cancer vaccines

Dana-Farber Cancer Institute researchers will present findings at the 2026 European Society . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products